These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 4124093)
21. Renal cell carcinoma: a preliminary clinical trial of methodichlorophen (D.D.M.P.). Hindmarsh JR; Hall RR; Kulatilake AE Clin Oncol; 1979 Mar; 5(1):11-5. PubMed ID: 421383 [No Abstract] [Full Text] [Related]
22. Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man. Cavallito JC; Nichol CA; Brenckman WD; Deangelis RL; Stickney DR; Simmons WS; Sigel CW Drug Metab Dispos; 1978; 6(3):329-37. PubMed ID: 26555 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of antimalarial drugs: their therapeutic and toxicological implications. Salako LA Ann Ist Super Sanita; 1985; 21(3):315-25. PubMed ID: 3914849 [No Abstract] [Full Text] [Related]
24. Standard and reduced doses of sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum in Tanzania, with determination of drug concentrations and susceptibility in vitro. Hellgren U; Kihamia CM; Bergqvist Y; Lebbad M; Premji Z; Rombo L Trans R Soc Trop Med Hyg; 1990; 84(4):469-72. PubMed ID: 2091329 [TBL] [Abstract][Full Text] [Related]
25. [Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS]. Langmann P; Klinker H; Richter E Dtsch Med Wochenschr; 1995 May; 120(21):780-1. PubMed ID: 7781508 [No Abstract] [Full Text] [Related]
26. [Megaloblastic anaemia due to excessively prolonged administration of pyrimethamine (author's transl)]. Masana L; Nubiola AR; Rubiés-Prat J Sangre (Barc); 1981; 26(2):216-20. PubMed ID: 7280928 [No Abstract] [Full Text] [Related]
28. A randomized safety and tolerability trial of artesunate plus sulfadoxine--pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children. Doherty JF; Sadiq AD; Bayo L; Alloueche A; Olliaro P; Milligan P; von Seidlein L; Pinder M Trans R Soc Trop Med Hyg; 1999; 93(5):543-6. PubMed ID: 10696418 [TBL] [Abstract][Full Text] [Related]
29. The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria. Winstanley PA; Watkins WM; Newton CR; Nevill C; Mberu E; Warn PA; Waruiru CM; Mwangi IN; Warrell DA; Marsh K Br J Clin Pharmacol; 1992 Feb; 33(2):143-8. PubMed ID: 1550695 [TBL] [Abstract][Full Text] [Related]
31. [Recommendations for the treatment of prenatal toxoplasma infection in the child. German Society of Pediatric Infectiology e.V. (DGPI), "Parasitology" Study Group]. Döhring-Schwerdtfeger E; Leichsenring M; Liefke U; Padelt H; Sitzmann FC; Stehr K; Zimmermann PH Klin Padiatr; 1995; 207(1):38-41. PubMed ID: 7885018 [No Abstract] [Full Text] [Related]
32. [Sequelae of combined toxoplasmosis therapy in childhood]. Weiland R; Otto FM Dtsch Gesundheitsw; 1968 May; 23(18):830-5. PubMed ID: 5680323 [No Abstract] [Full Text] [Related]
33. Pharmacokinetic interactions of artemether and pyrimethamine in healthy male Thais. Tan-ariya P; Na-Bangchang K; Ubalee R; Thanavibul A; Thipawangkosol P; Karbwang J Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):18-23. PubMed ID: 9740261 [TBL] [Abstract][Full Text] [Related]
34. Effects of low concentrations of pyrimethamine on human bone marrow cells in vitro: possible implications for malaria prophylaxis. Wickramasinghe SN; Litwinczuk RA J Trop Med Hyg; 1981 Dec; 84(6):233-8. PubMed ID: 7321070 [TBL] [Abstract][Full Text] [Related]
35. Bio-hazards and drug reactions: a cautionary tale. Peters E; Seaton A Scand J Infect Dis; 2005; 37(4):312-3. PubMed ID: 15804671 [TBL] [Abstract][Full Text] [Related]
36. Phase I trial of metoprine in patients with advanced cancer. Currie VE; Kempin SJ; Young CW Cancer Treat Rep; 1980; 64(8-9):951-6. PubMed ID: 6969632 [TBL] [Abstract][Full Text] [Related]
37. Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. Weidekamm E; Plozza-Nottebrock H; Forgo I; Dubach UC Bull World Health Organ; 1982; 60(1):115-22. PubMed ID: 6979415 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of intravenously and orally administered pyrimethamine in horses. Clarke CR; Burrows GE; MacAllister CG; Spillers DK; Ewing P; Lauer AK Am J Vet Res; 1992 Dec; 53(12):2292-5. PubMed ID: 1476310 [TBL] [Abstract][Full Text] [Related]
39. [Mass spectrometry in the verification of pyrimethamine poisoning]. Vereczkey L; Klátyilc M; Bárdosi Z; Jemnitz K; Vékey K Orv Hetil; 1998 Jul; 139(27):1639-42. PubMed ID: 9685804 [TBL] [Abstract][Full Text] [Related]
40. [Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?]. Genuini M; Freihuber C; Girard I; de Montgolfier I; Kieffer F; Mitanchez D Arch Pediatr; 2011 Oct; 18(10):1084-6. PubMed ID: 21885264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]